In fission yeast, cdc18p plays a critical role in bringing about the onset of S phase. We show that cdc18p expression is subject to a complex sequence of cell cycle controls which ensure that cdc18p levels rise dramatically as cells exit mitosis, before the appearance of CDK activity in G 1 . We find that transcription of cdc18, together with the transcription of other cdc10p/ res1p targets, is first initiated as cells enter mitosis and continues even in cells arrested in mitosis with highly condensed chromatin. However, cdc18p cannot accumulate during mitosis because it is targeted for proteolysis by mitotic cdc2p-protein kinase-mediated phosphorylation. On exit from mitosis, the cdc2p mitotic kinase activity falls, stabilizing cdc18p, which then rapidly accumulates. This combination of mitotic transcription and CDK-mediated proteolysis ensures that progression through mitosis simultaneously prepares cells for DNA replication. During S phase, cdc18 transcription is then switched off, preventing the reinitiation of DNA synthesis until the completion of the next round of mitosis.
Introduction
In eukaryotes, the decision to undergo DNA replication is subject to several controls. In late G 1 , cells assess internal and external cues before committing themselves to a mitotic cycle and entry into S phase. These controls are best understood in the budding yeast Saccharomyces cerevisiae. In this organism, the Cln3p/Cdc28p protein kinase becomes activated early in G 1 (Tyers et al., 1993; Dirick et al., 1995) leading to an increase in the activity of two transcriptional complexes, Swi4p/Swi6p and Mbp1p/ Swi6p (Andrews and Herskowitz, 1989; Nasmyth and Dirick, 1991; Ogas et al., 1991) . Targets of this periodic transcription include the enzymatic functions necessary to bring about DNA replication, e.g. ribonucleotide reductase (Johnston and Lowndes, 1992; Breeden, 1996) and additional cyclin partners for Cdc28p which drive the initiation of S phase (Epstein and Cross, 1992; Schwob and Nasmyth, 1993) . In metazoan cells, Cdk4,6/cyclin D kinase activity accumulates in G 1 , inactivating Rb (Sherr, 1995) . This frees the E2F/DP1 transcription factor from repression, enabling the transcription of cyclins A and E. These cyclins, together with a CDK subunit, then initiate DNA replication.
Initiation requires conserved protein complexes acting at origins of replication (Stillman, 1996) . The origin recognition complex (ORC) binds origins of replication throughout the S.cerevisiae cell cycle (Bell and Stillman, 1992; Diffley and Cocker, 1992) . Then in G 1 , Cdc6p and MCM proteins are recruited to the origin by the ORC complex Aparicio et al., 1997; Tanaka et al., 1997) giving rise to an extended 'prereplicative' complex at the origin, as visualized by genomic footprinting (Diffley and Cocker, 1992; Diffley et al., 1994) . Late in G 1 , cyclin/CDK activity is required to catalyse the initiation of DNA synthesis, presumably by phosphorylating components at the origin (Stillman, 1996) . After initiation, Cdc6p is lost from chromatin, while MCM proteins gradually dissociate during DNA synthesis (Chong et al., 1995; Kubota et al., 1995; Coleman et al., 1996; Aparicio et al., 1997) .
The control of DNA replication in the fission yeast Schizosaccharomyces pombe shows both similarities and differences to that in S.cerevisiae. In S.pombe, the S-phase transcriptional machinery is composed of cdc10p, res1p, res2p and rep2p (Aves et al., 1985; Tanaka et al., 1992; Caligiuri and Beach, 1993; Miyamoto et al., 1994; Zhu et al., 1994; Nakashima et al., 1995; Baum et al., 1997) . Cdc10p, res1p and res2p share homology with Swi4p, Swi6p and Mbp1p from budding yeast. The targets of this transcriptional machinery are expressed periodically in the cell cycle and include cdc18, cdc22, cdt1 and cig2 (Gordon and Fantes, 1986; Kelly et al., 1993; Hofmann and Beach, 1994; Obara-Ishihara and Okayama 1994) . Cdc18 is homologous to CDC6 in S.cerevisiae and is thought to be a critical target of cdc10 in fission yeast, as temperaturesensitive mutations in cdc10 can be rescued by the ectopic expression of cdc18 even at a high restrictive temperature (Kelly et al., 1993) . Since the onset of S phase in fission yeast requires both periodic transcription and B-type cyclin/CDK activity, it is often assumed that the control of S-phase transcription in both yeasts is controlled in an analogous fashion. However, recent evidence suggests that this may not be the case because, in S.pombe, cdc10p/ res1p mediated transcription is active in G 1 , independently of the G 1 cdc2p protein kinase (Baum et al., 1997) .
Because fission yeast cells are unable to replicate their DNA in the absence of cdc18 (Kelly et al., 1993) , while high-level over-expression of cdc18p drives cells into a cycle of continuous DNA synthesis without mitosis (Nishitani and Nurse, 1995; Muzi-Falconi et al., 1996) , the periodic accumulation of cdc18p through the cell cycle is likely to be important for orderly cell cycle progression. This cyclic accumulation of cdc18p is controlled in part by periodic cdc18 transcription (Kelly et al., 1993) . In addition, CDK activity promotes the proteolysis of cdc18p. This has been suggested to be important in S-and G 2 -phase cells to prevent the re-initiation of DNA replication (Elsasser et al., 1996; Jallepalli et al., 1997; Lopez-Girona et al., 1998) . In S.pombe and human cells, dramatic reductions in G 2 CDK activity can also perturb the cell cycle, causing cells to re-enter S phase without first undergoing nuclear division (Broek et al, 1991; Hayles et al., 1994; Moreno and Nurse, 1994; Itzhaki et al., 1997) . Moreover, in S.cerevisiae, G 2 CLB/CDK activity inhibits the formation of the pre-replicative complex Tanaka et al., 1997) , and in Xenopus extracts CDK activity blocks the ability of MCMs to bind to DNA (Adachi and Laemmli, 1994; Hua et al., 1997) . Therefore, it is likely that ordered passage through the eukaryotic cell cycle is controlled by the interplay of components of the pre-replicative complex, in particular Cdc6p/cdc18p, with the cyclic activity of CDK-cyclin complexes.
Previously, it was thought that events leading to the onset of DNA replication in eukaryotes were initiated in G 1 in response to the re-accumulation of CDK activity. In this model, G 1 CDK-cyclin complexes activate S-phase transcription, leading to the accumulation of cdc18p/ Cdc6p in late G 1 and the initiation of S phase. The same G 1 CDK activity was also shown to destabilize cdc18p/ Cdc6p. This leaves it unclear how cdc18p is able to accumulate in the presence of G 1 CDK activity to perform its essential S-phase function. In this paper we re-assess the timing of periodic S-phase transcription in fission yeast. Unexpectedly, we show that cdc18 is first transcribed early in mitosis in cells with condensed chromatin and in the presence of high levels of the mitotic kinase. Despite the accumulation of cdc18 transcripts, cdc18p does not appear until cells exit mitosis, because it is destabilized by cdc2p phosphorylation of its N-terminus. Therefore, the combination of cdc18 transcription during mitosis and of CDK-mediated cdc18p proteolysis gives rise to the timely production of cdc18p at the exit from mitosis. In view of this, the CDK-mediated proteolysis of cdc18p may function primarily to prevent the initiation of Sphase events within mitosis. Thus, controls over cdc18p expression contribute to orderly cell cycle progression by linking passage through mitosis to the setting-up of the subsequent S phase.
Results

cdc10-dependent transcription activated early in mitosis
The transcription of several components required for S phase in fission yeast such as cdc18, cdc22 and cdt1, is dependent upon the transcription factor cdc10p. To determine the cell cycle timing of cdc10-dependent transcription, we followed transcription through a synchronous cell cycle. cdc25-22 cells were incubated at the restrictive temperature of 36°C for 4 h to arrest them at the G 2 /M boundary, and were then shifted to the permissive temperature of 25°C, releasing cells into mitosis and a subsequent cell cycle (Figure 1 ). The accumulation of cdc18 mRNA was compared with two markers of progression through 5690 Fig. 1 . cdc18 is expressed in mitosis in cells released from a cdc25 block. (A) cdc18 mRNA levels were monitored through a synchronous mitosis. cdc25-22 cells were shifted to 36°C for 4 h to arrest them at the G 2 /M boundary and then synchronously released into mitosis and the subsequent round of the cell cycle at 25°C. (B) The Northern in (A) was quantified by PhosphorImager analysis and the ratio cdc18/his3 plotted. Mitotic progression was monitored by measuring cdc13p-associated H1 histone kinase activity and by visualizing the percentage of cells with short spindles by immunofluorescence. mitosis ( Figure 1B) , the presence of the cdc13p associated protein kinase and the state of the mitotic spindle. cdc18 message levels rose within 20 min of the shift to the permissive temperature, just as the levels of cdc13p-associated H1 kinase and the percentage of cells with a short spindle were increasing ( Figure 1B) . cdc18 expression persisted into G 1 , decreasing as cells passed from G 1 into S and G 2 phase. Two other cdc10 targets, cdc22 and cdt1, showed a similar profile of expression (data not shown). These data suggest that a number of cdc10 target genes are transcribed from early mitosis until late G 1 /Sphase. Similar results were obtained using a synchronous culture of cdc25-22 cells previously starved of nitrogen (data not shown). This starvation prevents cell growth and thereby rules out an effect of cell size on the timing of S-phase transcription.
To verify that cdc10-dependent transcription is switched on early in mitosis, we next assayed transcript levels in cells arrested in mitosis using mutations in nuc2 or nda3 and by the expression of cdc13Δ90. nuc2-663 cells are defective in the APC complex (or 'cyclosome') which controls the proteolysis of B-type cyclins and other specific targets (Kumada et al., 1995; Ruderman and Hershko, 1995; King et al., 1996) . Since the APC is essential for the initiation of anaphase and the exit from mitosis, nuc2 ts cells accumulate at the metaphase-anaphase transition at the restrictive temperature, with high levels of mitotic (A) A synchronous culture of nuc2-663 cells prepared by centrifugal elutriation at 25°C was shifted to 36°C. cdc18, cdc22 and his3 mRNAs were monitored as cells entered mitosis, and DAPI was used to quantify condensed chromatin. (B) An asynchronous population of nda3-km311 cells grown at 32°C was shifted to a restrictive temperature, 20°C, to arrest cells at metaphase. A Northern was prepared and probed for cdc18, cdt1 and his3. Cells with condensed chromatin were visualized using DAPI. The experiment was then repeated and a Northern probed for cdc18, cdc22, cig2 and his3 mRNAs. (C) A nuclear run-on experiment was used to assess ongoing transcription in a mitotic block. Nascent transcription was analysed in cells arrested at the onset of S phase by the addition of 11 mM HU, in nda3-km311 and wild-type cells after 6 h at 18°C, and in cdc10-129 cells at 36°C. Radiolabelled RNA was isolated and hybridized to ssDNA. cdc18, cdc2 and ura4 probes in both sense and anti-sense orientations, together with vector alone, were used to determine the background signal. Raw data is presented together with quantification by PhosphorImager analysis.
cdc2p/cdc13p kinase activity and highly condensed chromatin (Kumada, et al., 1995) . To arrest synchronously nuc2 ts cells in mitosis, early G 2 cells were isolated by centrifugal elutriation at 25°C, then shifted to 36°C and sampled as they entered the mitotic block. cdc18 and cdc22 transcripts appeared as cells accumulated condensed chromatin, visualized using DAPI (Figure 2A ). Histone transcript levels did not increase (data not shown), indicating that cells did not leak through the block into S phase.
The accumulation of cdc10-dependent transcripts during a metaphase block was confirmed using a cold-sensitive mutation in β-tubulin, nda3-km311, which arrests cells at the metaphase-anaphase transition as the result of a spindle checkpoint, with high levels of cdc2p/cdc13p kinase activity and condensed chromatin (Umesono et al., 1983; Hiraoka et al., 1984) . The arrest is transient at 20°C and more prolonged at 18°C. cdc18, cdt1 and cdc22 mRNAs accumulated 3-4 h after nda3 cells were shifted to a restrictive temperature (20°C), in parallel with the proportion of cells containing condensed chromatin ( Figure 2B ). The levels of cdc18, cdt1 and cdc22 mRNAs fell as cells leaked through the mitotic block. cig2 transcript levels were not elevated during the arrest, suggesting that cig2 may be subject to different cell cycle controls ( Figure 2B ).
To test whether cdc18 is actively transcribed during mitosis, a nuclear run-on experiment was carried out (Humphrey et al., 1994) . Cells were permeabilized and transcriptional elongation assayed by the incorporation of radioactive UTP into nascent mRNA strands. Ongoing cdc18 transcription was compared in exponentially growing cells and in cells arrested in mitosis and normalized to levels of cdc2 transcription (see Materials and methods for details). In cells arrested at the nda3 cs block or in S phase (in HU), the rate of ongoing transcription was elevated compared with that of control wild-type cells. As expected, cdc18 transcription was reduced in cdc10-129 cells at 36°C ( Figure 2C ). These results indicate, unexpectedly, that cdc18 is actively transcribed during mitosis, leading to the accumulation of cdc18 mRNA.
To show that the mitotic expression of cdc18 results from cdc10-dependent transcription, a strain was constructed carrying the nda3 cs mutation together with cdc10-129 ( Figure 3A ). Cells were first arrested in mitosis by incubation at 18°C for 6 h and thiabendazole was added to delay mitotic exit. Cells were then shifted to 36°C to inactivate cdc10 ts in the continued presence of thiabendazole. The temperature shift had no effect on the levels of cdc18 mRNA in control cells, but in cells carrying a cdc10 ts allele, cdc18 mRNA levels fell to background within 5 min of the shift to 36°C. This demonstrates that the high levels of cdc18 mRNA observed in mitotic cells result from active, cdc10-dependent transcription. This result was confirmed by arresting cells in mitosis using over-expression of the non-degradable B-type cyclin, cdc13Δ90 ( Figure 3B ) (Murray et al., 1989) . In this situation cells enter mitosis, but cannot exit into G 1 or decondense their chromosomes, since the cdc2p/cdc13p mitotic kinase cannot be inactivated. Upon induction of cdc13Δ90 expression in the wild type, cells underwent mitotic arrest and cdc18 mRNA rose to levels similar to those observed in an HU-induced arrest ( Figure 3B , lanes 1-4). To confirm that this was the result of ongoing cdc10-dependent transcription, cdc13Δ90 was expressed in cdc10 ts ( Figure 3B , lanes 5 and 6) and res1Δ backgrounds ( Figure 3B , lanes 7-9). In the cdc10-129 strain, upon induction of cdc13Δ90 at 25°C, cdc18 mRNA levels became elevated as cells entered the mitotic arrest, but then decreased to low levels after the shift to 36°C. In the res1Δ strain, in which S-phase transcription is constitutive through the cell cycle (Baum et al., 1997) , Fig. 3 . The mitotic expression of cdc18 is dependent on cdc10 function and cdc18p cannot accumulate until exit from mitosis. (A) nda3 and nda3 cdc10-129 cells were arrested in mitosis for 6 h at 18°C, and 150 μg/ml of thiabendazole was added prior to a shift to 36°C. cdc18 and his3 transcript levels were monitored by Northern analysis. (B) Wild-type, cdc10-129 and res1Δ strains were used containing an integrated copy of cdc13Δ90 behind the nmt41 promoter. Wild-type cells were assayed 14 and 16 h after thiamine removal (2-4 h after the start of derepression). Cells arrested in HU for 4 h were used for comparison. res1Δ cells were sampled after 15 and 17 h after thiamine removal, while cdc10-129 cells were grown for 21 h at 25°C and then shifted to 36°C for 30 min to inactivate cdc10 ts . Northern blots were used to assess the levels of cdc18 and his3 mRNA. (C) Exponentially growing nda3-km311 and wild-type cells grown at 32°C were shifted to 18°C for 6 h and then to 36°C. Protein samples were analysed by Western blotting using anti-cdc18p and anti-α-tubulin antibodies. (D) A similar experiment presented to show the synchrony of anaphase obtained using this procedure; nuclei were observed by DAPI staining of fixed cells. no increase in cdc18 mRNA was seen during mitotic arrest. We conclude that cdc10-dependent transcription is active from early mitosis through until G 1 /S phase.
Since cdc10-dependent transcription is active in a metaphase arrest, we explored whether cdc10 is able to complete its essential S-phase function during the mitosis of the previous cell cycle. In order to do this, nda3-km311, cdc10-129 and nda3-km311 cells were arrested in metaphase for 6 h at 18°C and then shifted to 36°C to inactivate cdc10 ts . Subsequently, whereas cdc10 ϩ cells underwent DNA replication at 36°C, cdc10 ts cells were unable to do so (FACS data not shown). Therefore, cdc10 cannot complete its S-phase function during a mitotic arrest.
We next investigated whether the high levels of cdc18 5692 transcription during mitosis result in the accumulation of cdc18p. A mitotic arrest was induced by shifting nda3-km311 mutant cells to 18°C for 6 h. Cells were then shifted to 32°C to release them into the subsequent cycle ( Figure 3C ). Cdc18p was undetectable during the mitotic block, in spite of the elevated levels of cdc18 mRNA ( Figure 3A ). However, cdc18p accumulated to high levels within 5 min of release from the mitotic arrest, at the same time at which the majority of cells initiated anaphase.
There was no concominant increase in cdc18 mRNA levels (data not shown). nda3 cells were stained 5 and 10 min after release from the mitotic block with DAPI to visualize anaphase ( Figure 3D ). In the wild-type control, the only observed change was a decrease in cdc18p levels after the temperature shift, possibly due to the transient mitotic arrest brought about by a shift to higher temperatures (Nurse, 1975) ( Figure 3C , right-hand panel). The inability of cdc18p to accumulate in a metaphase arrest may explain why the cdc10 function is not completed in cells arrested in an nda3 block.
Mitotic instability of cdc18p is regulated by cdc2p phosphorylation
To test whether upstream regulatory regions of the cdc18 gene are important in bringing about this increase in cdc18p levels on exit from mitosis, either through effects on transcription or translation, the cdc18 ORF was fused with the weak regulatable nmt81 promoter. This construct was introduced into an nda3 cs mutant deleted for the endogenous cdc18 gene, and a block-and-release experiment was performed. Like the endogenous full-length cdc18 gene, cdc18p expressed from the nmt promoter was barely detectable during mitotic arrest, but accumulated rapidly after release ( Figure 4B ). Therefore, the rapid accumulation of cdc18p upon mitotic exit is probably the consequence of regulated proteolysis. In agreement with this, it has recently been shown that cdc18p is subject to proteolytic control mediated by ubiquitination, targeting the protein to the proteosome (Kominami and Toda, 1997) . Cdc18p contains six cdc2 phosphorylation consensus sites, five located in the N-terminal region ( Figure 4A ). Phosphorylation of these sites by the S-phase cdc2p kinase destabilizes cdc18p in exponential cultures and during S phase . To investigate whether cdc2p-dependent phosphorylation is important for regulating cdc18p levels during mitosis, we constructed several mutant forms of cdc18p ( Figure 4A ), either lacking the entire N-terminus, containing five cdc2 consensus phosphorylation sites (S/T-P-X-K/R), or carrying mutations in these cdc2 sites.
First, we investigated whether phosphorylation of the N-terminal portion of cdc18p plays a role in determining cdc18p levels during mitosis. In initial experiments, two N-terminal truncations were constructed, both of which lacked five of the six cdc2 consensus phosphorylation sites ( Figure 4A ). These truncated versions of cdc18p were constitutively expressed from the weak nmt81 promoter, at close to endogenous levels, in an nda3 cs mutant strain. Cells were then subjected to an nda3 block and release protocol (as in Figure 3C ). Although the endogenous cdc18p was unable to accumulate in mitosis, removal of the N-terminal region containing the cdc2 consensus sites expressing their only copy of cdc18p from the nmt81 promoter on a plasmid were subjected to an nda3 block-and-release protocol, (lanes 1-3). Cells were released at 32°C after 6 h at 18°C, and Westerns probed with anti-cdc18p antibody. (C-D) nda3-km311 cells ectopically expressing truncated versions of cdc18p lacking the N-terminal (C) 149 amino acids (d55) and (D) 135 amino acids (d5) from the nmt81 promoter were subjected to the same nda3 block and release protocol. (E) An alternative synchronization procedure was used in which cdc25-22 cells expressing cdc18-d5 were followed through a synchronous mitosis, G 1 and S phase. In all cases, the levels of cdc18p were monitored using a polyclonal antibody raised against cdc18p.
in cdc18-d55 was sufficient to stabilize the protein in the nda3 block ( Figure 4C, lane 1) . Furthermore, the level of cdc18-d55 protein did not increase significantly upon release into G 1 ( Figure 4C lanes 2-3) . The less extensive truncation of cdc18, cdc18-d5, behaved similarly ( Figure  4D ). The observation that cdc18p lacking its N-terminal portion is stable during mitosis was confirmed using a cdc25-22 mutant to synchronize cells ( Figure 4E ). cdc18-d5 protein was expressed from the nmt promoter during a block-and-release experiment. While wild-type cdc18p was absent in G 2 and accumulated transiently in G 1 of the subsequent cycle (peaking 60 min after release from the 5693 block), the truncated version remained at constant levels throughout the cell cycle. This shows that the N-terminus is required for the periodic instability of cdc18p, targeting cdc18p for degradation in mitosis. In additional experiments, the full-length protein or N-terminal portions of cdc18p were shown by co-immunoprecipitation to bind to cdc2p in vivo, while the C-terminal truncations used in this experiment were unable to bind cdc2p (data not shown), suggesting that the N-terminus of the protein mediates the association of cdc18p with cdc2p. It is also possible that the N-terminus is required for the interaction of cdc18p with the proteolytic machinery itself (Drury et al., 1997) .
Next, two cdc18p mutants were constructed to test whether the N-terminal cdc2 sites mediate the mitotic instability of cdc18p, one in which the five N-terminal cdc2 sites were mutated to a non-phosphorylatable alanine (cdc2-5*) and a second version carrying mutations at all six cdc2 sites (cdc2-6*) ( Figure 4A ). We confirmed previously published data which show that mutation of these cdc2 sites stabilizes cdc18p and that cdc2p activity is required for phosphorylation of these consensus sites in vivo LopezGirona et al., 1998) . Myc-tagged cdc18p constructs were ectopically expressed in wild-type cells from the nmt promoter. When the nmt promoter was switched off, wildtype tagged cdc18p disappeared within 30 min (Figures 5A) but the cdc2-5* and cdc2-6* mutant proteins were still detectable 120 min after the addition of thiamine. Therefore, mutation of the cdc2 consensus phosphorylation sites within cdc18p stabilizes the protein. To confirm that cdc18p phosphorylation is dependent upon the cdc2p protein kinase in vivo, these same constructs were then expressed in a cdc2 ts strain. At 25°C, when the cdc2p kinase was active, the mobility of wild-type cdc18p was shifted towards higher molecular weights. In contrast, the cdc2-5* and cdc2-6* mutant proteins, at both the permissive and restrictive temperatures, ran with the same mobility as the wild-type cdc18p in cells with inactive cdc2 function ( Figure 5B ). This implies that cdc2p phosphorylates the wild-type protein at some or all of these consensus phosphorylation sites in vivo.
It is possible that different mechanisms mediate cdc18p turnover at different times during the cell cycle. Therefore, to observe the effect of these mutations on the mitotic instability of cdc18p and on its accumulation through the cell cycle, nda3-km311 cells expressing myc-tagged proteins from the nmt promoter were subjected to a mitotic block and release ( Figure 5C ). While the endogenous and tagged wild-type cdc18p behaved similarly, mutation of the cdc2 sites stabilized cdc18p during mitosis. Also, the levels of mutant cdc18p did not increase further upon the release into G 1 of the subsequent cycle. This result was confirmed in a cdc25 block and release experiment ( Figure  5D ). Again, while the endogenous or myc-tagged wildtype cdc18p did not accumulate until 40 min after release from G 2 , (coinciding approximately with the decrease in mitotic kinase activity in Figure 1B) , the cdc2-6* mutant form of cdc18p remained stable during mitosis and throughout the subsequent cycle. Therefore, the cdc2 consensus phosphorylation sites in the cdc18p N-terminus are required for the mitotic instability of cdc18p. 5 . Mutation of the cdc2 consensus phosphorylation sites contained within cdc18p prevents its periodic instability. (A) Myc-tagged cdc18p and tagged cdc2 site mutant versions of the protein were expressed from the nmt81 promoter; cdc18, cdc18-cdc2-5* and cdc18-cdc2-6*. Thiamine was added, and the level of myc-cdc18p assessed using anti-myc antibody. (B) The ability of cdc2p to phosphorylate cdc18p at the consensus cdc2 sites was assessed in vivo. cdc2-33 cells were transformed with myc-tagged wild-type and cdc2 consensus site mutant versions of cdc18p behind the nmt81 promoter. Cells were shifted to the restrictive temperature for 30 min to remove cdc2p activity. The wild type was shifted back to 25°C for 30 min to re-activate the cdc2p kinase. The Western was probed with anti-myc antibodies to visualize the tagged protein. The same constructs were expressed in (C) nda3-km311 (D) and cdc25-22 cells. Cdc18p was monitored using a polyclonal anti-cdc18p antibody in an nda3 block and after the release (C), and in a cdc25 block-and-release experiment (D).
Discussion
The work presented in this paper investigates the regulatory mechanisms controlling the periodic expression of cdc18p, a key regulator of the decision to initiate DNA replication. We have found the following. (i) Transcription of cdc18 is activated as cells enter mitosis, leading to an accumu-lation of cdc18 mRNA during mitosis and G 1 . (ii) Remarkably, transcription of cdc18 continues even in cells blocked in metaphase with highly condensed chromosomes. (iii) This cdc18 transcription is accompanied by the mitotic transcription of other cdc10-dependent genes, such as cdc22 and cdt1, and requires the continued activity of the cdc10p 'start' transcription factor (homologous to the budding yeast Swi6p 'start' transcription factor). This means that so called 'start' transcription is initiated during mitosis, not in late G 1 as previously thought. (iv) Despite the presence of high levels of cdc18 mRNA during mitosis, cdc18p is unable to accumulate until the exit from mitosis. (v) Cdc18p is stabilized by mutation of the consensus cdc2 phosphorylation sites located in its N-terminus, leading to the accumulation of cdc18p during mitosis and throughout the cell cycle. Furthermore, phosphorylation of these sites is dependent upon cdc2p activity in vivo. Therefore, the high level of the cdc2p/cdc13p protein kinase activity in mitotic cells prevents cdc18p from accumulating. However, since cdc18 is already being actively transcribed and translated in metaphase, cdc18p can accumulate as soon as the cdc2p mitotic kinase activity falls. In this way, the combined regulation of cdc18 transcription and cdc2p-mediated proteolysis leads to the transient accumulation of cdc18p immediately following the exit from mitosis, before the re-accumulation of CDK activity in late G 1 .
The finding that cdc10-dependent transcription is activated in cells with condensed chromatin is surprising since it is widely accepted that active transcription cannot take place in mitotic chromatin. In metazoan nuclei, there is a clear general inhibition of transcription during mitosis (Johnson and Holland, 1965) . In these cells transcription is switched off by the cdc2p mitotic kinase (Hartl et al., 1993; Gottesfeld et al., 1994; White et al., 1995; Leresche et al., 1996; Gebara et al., 1997) . Mitotic CDK activity has been shown to inhibit RNA polymerase function directly, both in vivo and in vitro (Hartl et al., 1993; Gottesfeld et al., 1994; White et al., 1995; Leresche et al., 1996; Segil et al., 1996; Gebara et al., 1997) and is able to clear certain transcription factors from the mitotic chromatin (Roberts et al., 1991; Martinez-Balbas et al., 1995; Segil et al., 1996) . In fission yeast, however, there is no evidence to suggest that transcription is highly repressed during mitosis, since the rate of RNA synthesis is maintained during passage through mitosis in synchronous cultures (Creanor and Mitchison, 1982; Elliot, 1983) and in cells arrested in mitosis Mitchison, 1986, 1987) . Nevertheless, it is surprising to find that the transcription of specific genes is activated as fission yeast cells enter mitosis and maintained in cells arrested in mitosis with highly condensed chromatin. Therefore, specific mechanisms may exist to enable cdc10p to activate transcription during mitosis. First, transcription factors need to target sites within condensed chromatin. This problem could be circumvented if cdc10p were bound to the DNA in G 2 cells in an inactive state (McInerny et al., 1995; Baum et al., 1997) , thereby marking the promoters of cdc10 targets for potential activation upon entry into mitosis. Alternatively, active promoters might be maintained in a more decondensed state throughout mitosis. In addition, cdc10p must also recruit active RNA pol II to promoters in mitotic chromatin and local decondensation or breathing of the chromatin may be required to enable the RNA polymerase to traverse the gene. Although the mechanisms controlling the periodicity of cdc10-dependent transcription remain unresolved, this study makes it clear that the activation of cdc10p/res1p is likely to be linked to mitotic events, not events, e.g. growth, during G 1 . Chromatin condensation per se is probably not responsible for the activation signal because the ectopic expression of NimA, which induces condensation without mitosis (O'Connell et al., 1994) , does not lead to an increase in cdc18 transcript levels (data not shown). One possibility is that the mitotic activation of cdc18 transcription is brought about by phosphorylation of a component(s) of the cdc10p complex by cdc2p at the onset of mitosis.
CDC6, the budding yeast homologue of cdc18 was initially thought to be expressed in late G 1 (Zhou and Jong, 1990) , but more recently has been shown to be expressed at telophase (at the exit from mitosis) (Zwerschke et al., 1994; Piatti et al., 1995) in an SWI5-dependent manner (Piatti et al., 1995) , and to be under the transcriptional regulation of Mcm1p (McInerny et al., 1997) . From these data it has been proposed that CDC6 is expressed twice during the cell cycle, first at the exit from mitosis and then again at the end of G 1 (Piatti et al., 1995; Detweiler and Li, 1997) . The second burst of CDC6 transcription may be redundant because the M/G 1 burst suffices for S phase, even in cells which pause in G 1 (Piatti et al., 1995) . This is reminiscent of the situation in S.pombe, in which cdc18 mRNA appears to accumulate in G 1 upon re-entry into the cell cycle after nitrogen starvation (Baum et al., 1997) , and in mitosis in cycling cells (this study). The different technical approaches required to follow transcription through the cell cycle (in cells exiting mitosis or during re-growth from G 1 arrest) may yield different profiles of expression, and in fact, two peaks of CDC6/cdc18 expression have not been observed within a single cell cycle in synchronous cultures of either organism. Moreover, we have preliminary results suggesting that in budding yeast, CDC6 is expressed to high levels in cells arrested at metaphase, i.e. in mitosis itelf, using temperature-sensitive mutations in cdc20 and cdc16 or by the addition of nocodazole (data not shown). Further investigation is required to firmly establish whether 'start' transcription factors assist in the mitotic expression of CDC6 in S.cerevisiae. However, it seems that in both yeasts, S-phase genes are first transcribed in mitosis, suggesting a conserved function for this window of gene expression. Whether this is likely to be the case for transcription of S-phase genes (e.g. by E2F) in mammalian cells remains to be seen.
Despite the accumulation of cdc18 transcripts, cdc18p is unstable and cannot accumulate during mitosis. However, an N-terminal truncation of cdc18p removing five of the six S/T-P-X-R/K consensus target sites for cdc2p-mediated phosphorylation within the protein, or mutation of these motifs, stabilizes cdc18p in mitosis. Therefore, the mitotic instability of cdc18p is conferred upon the protein by these N-terminal sites. The cdc2p protein kinase is likely to be directly responsible for this phosphorylation, since cdc18p has been shown to interact with cdc2p (Jallepalli and Kelly, 1996; Leatherwood et al., 1996; Brown et al., 1997; Jallepalli et al., 1997; Lopez-Girona et al., 1998) , an interaction which is mediated by the N-terminus (H.Nishitani, unpublished data). Finally, cdc2p has also been shown to phosphorylate cdc18p on these sites in vivo Lopez-Girona et al., 1998; this study) . Therefore cdc2p phosphorylates cdc18p at the five N-terminal cdc2 consensus sites destabilizing the protein during mitosis. The pop1p complex may direct phosphorylated cdc18p to the proteosome (Kominami and Toda, 1997) . Like cdc18p, Cdc6p in S.cerevisiae is also subject to proteolysis via ubiquitin ligation, catalysed by the Cdc4p complex Drury et al, 1997) , the counterpart to the pop1p complex in S.pombe (Kominani and Toda, 1997) . Since Cdc4p binds to the N-terminus of Cdc6p (Drury et al., 1997) , additional sequences in the N-terminal region of cdc18p may also be important for the interaction of cdc18p with the pop1p complex. If, as previously thought, cdc18p was first synthesized in late G 1 , it is not clear how cdc18p, which is destabilized by cdc2p, could carry out its S-phase function. This dilemma is resolved by the finding that cdc18 is first transcribed in mitosis. In this case, CDKmediated proteolysis is likely to be important to inhibit the initiation of S-phase events during mitosis itself.
Cdc6p has been shown to act at the G 1 /M boundary, at which time it is required to set up the 'pre-replicative complex' (Piatti et al., 1995; Cocker et al., 1996) . If cdc18p acts in a similar way, then CDK control over cdc18p stability establishes a direct link between the end of mitosis and DNA replication 'licensing' (Blow and Laskey, 1988) . Given the conserved function of the cdc18 homologue, CDC6, in promoting DNA replication in metazoa, and the requirement for CDK activity to inhibit endo-reduplication in mammalian cells, it is possible that expression of cdc18p/Cdc6p at the exit from mitosis is also conserved in all eukaryotes. Later in the cycle, cdc18p is degraded as renewed cdc2p protein kinase activity drives the initiation of DNA replication , while cdc10 is inactivated during S phase (Baum et al., 1997) . This prevents the re-initiation of S phase until cells pass through the subsequent round of mitosis, since as a result there is little or no cdc18p present in G 2 cells.
In conclusion, periodic transcription and CDK-regulated proteolysis act together in fission yeast to confine cdc18p function to the period from the end of mitosis until late G 1 (Figure 6 ). This contributes to the control ensuring that a single round of DNA replication follows each mitosis and leads to a simple scenario in which the prereplicative state is defined by both the presence of cdc18p and the absence of cdc2p protein kinase activity, and the post-replicative state by high cdc2p kinase levels and low levels of cdc18p.
Materials and methods
Schizosaccharomyces pombe strains and methods
All strains were derived from 972h -and 975h ϩ . All experiments were carried out in EMM2 minimal media, and growth conditions are as described previously (Moreno et al., 1991) . Unless otherwise stated, nda3-km311 strains (Umesono et al., 1983) were grown to exponential phase at 32°C and nda3-km311 cdc10-129 mutants at 28.5°C; nuc2-663 (Kumada et al., 1995) , cdc10-129 (Nurse and Bissett, 1981) , cdc25-22 (Fantes et al., 1979) and cdc2-33 (Nurse and Bissett, 1981) strains were grown at 25°C, res1Δ strains (Tanaka et al., 1992) at 30°C. The cdc13Δ90 and NimA integrants were derived from strains described previously (O'Connell et al., 1994; Stern and Nurse, 1997) . Different-strength thiamine-regulatable promoters, nmt1, nmt41 and nmt81, were used (Maundrell, 1990 (Maundrell, , 1993 . To generate the N-terminally truncated cdc18p mutants, cdc18-d5 (amino acids 1-135) and cdc18-d55 (1-149), the C-terminal fragments were amplified by PCR and subcloned into Rep81 and Rep41. The six threonine residues (at positions 10, 46, 60, 104, 134 and 374) were mutated to alanine using the Bio-Rad mutation kit and checked by sequencing. The myc-tagged versions were constructed using pRMH41 (a gift from Tony Carr).
Thiamine was used at 5 μg/ml, hydroxyurea (HU) at 11 mM and thiabendazole (TBZ), in DMSO, at 150 μg/ml. Cells were prepared for FACS and stained for propidium iodide as previously described (Sazer and Sherwood, 1990) . Microtubules were detected in methanol-fixed cells by immunofluorescence using the TAT1 antibody (a gift from K.Gull) and DNA visualized using DAPI, as described previously (Moreno et al., 1991) . Chromatin condensation was assessed visually.
Biochemical analysis
Western blotting was carried out as described previously (Moreno et al., 1991) , using extracts from boiled cells. The following antibodies were used for Western blotting: cdc18p polyclonal antibody at 1:1500 (Nishitani and Nurse, 1995) , α-tubulin monoclonal antibody at 1:10 000 (Sigma), myc monoclonal antibody at 1:1000 and a cig2p polyclonal antibody at 1:1000 (Stern and Nurse, 1997) .
H1 kinase assays were carried out using calf thymus Histone H1 (Sigma) as a substrate, as previously described (Correa-Bordes and . Kinase was precipitated from 500 μg of protein using 5 μl of polyclonal cdc13p antisera, SP4, followed by the addition of protein A-Sepharose (Pharmacia Biotech.).
Transcript analysis
For RNA preparation and Northern blot analysis, cultures were washed in STOP buffer (150 mM NaCl, 50 mM NaF, 10 mM EDTA, 1 mM NaN 3 pH 8) and frozen on dry ice. RNA was prepared using glass bead lysis in 0.1 M EDTA, 0.1M NaCl, 0.05M Tris pH 8.0, in the presence of phenol:chloroform:isoamyl alcohol (Gibco-BRL) and 0.4% SDS. RNA was precipitated after two phenol extractions by the addition of NH 4 OAc to 2.5 M and 2.5 vol. EtOH. Ten micrograms of sample RNA, as measured by an OD of 260/280, were denatured in 1ϫ MOPS, 8% formaldehyde and 67% formamide and run on a formaldehyde, 1.2% agarose gel in 1ϫ MOPS. The RNA was transferred by Northern blotting in 10ϫ SSC onto a GeneScreenPlus membrane (DuPont). Probes for blotting were prepared by random oligo-priming with [α-32 P]dATP using a Prime-It Kit (Stratagene). The membrane was hybridized overnight in 1% SDS, 10% dextran sulfate and 1M NaCl, and washed in 1% SDS 2ϫ SSC. The following template DNAs were used to generate probes: a cdc18 fragment from REP3X-cdc18 (Nishitani and Nurse, 1995) , a cig2 fragment from a genomic cig2 clone in pAL-SK (S.Moreno), a his3 fragment from a pKS his3 plasmid and a histone H2B fragment from pSJM211 (Matsumoto and Yanegida, 1985) . cdt1 and cdc22 probes were made from PCR fragments amplified from genomic DNA.
For the nuclear run-on, 2ϫ10 8 cells were filtered and washed with 5 ml ice cold TMN buffer (10 mM Tris-HCl, 5 mM MgCl 2 , 100 mM NaCl) and resuspended in 950 μl cold H 2 O, and 50 μl of 10% sarcosyl was added. The detergent was removed after 20 min and cells were resuspended in 120 μl of 'run-on' buffer (50 mM Tris-HCl pH 7.9; 80 mM MgCl 2 ; 500 mM KCl; 1 mM DTT; 1 mM rATP, 0.5 mM rGTP and rCTP; 100 units of RNase inhibitor (Sigma) and 100 μCi rUTP-α-32 P). The run on was carried out at 30°C for 10 min. Cells were then washed once in TMN buffer and broken to isolate labelled RNA as for a Northern blot. Isolated RNA was precipitated in the presence of 200 μg tRNA and washed in 70% ethanol. RNA was then dissolved in 100 μl 1ϫ TE, denatured at 95°C for 3 min, and then added to the prehybridized membrane in 3 ml of hybridization buffer (Humphrey et al., 1994) and incubated at 65°C for 2 days. Five micrograms of single-stranded DNA probe were absorbed onto the nylon membrane using a slot blot and cross-linked using the STRATAGENE Stratalinker. cdc18 KS was constructed from nmt1-cdc18 cDNA (Nishitani and Nurse, 1995) , ura4 KS from Rep4, (Maundrell, 1993) and cdc2 KS from the cdc2 ORF (Correa-Bordes et al., 1997) . Single-stranded DNA was prepared from cdc18 KS ϩ , cdc18 SK ϩ , ura4 KS ϩ , ura4 KS -, cdc2 KS ϩ , cdc2 KS -, KS ϩ and KS -plasmids, by infecting XL1-Blue with M13KO7 bacteriophage. Single-stranded phage DNA was purified using the Qiagen M13 kit. Bands were quantified by PhosphorImager analysis, the background subtracted (using the value of KS ϩ or KS -, as appropriate) and the cdc18/cdc2 value determined. (The relative values of cdc18/ura4 and cdc18/cdc2 were similar.)
